0001225208-22-009352.txt : 20220808
0001225208-22-009352.hdr.sgml : 20220808
20220808162325
ACCESSION NUMBER: 0001225208-22-009352
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220804
FILED AS OF DATE: 20220808
DATE AS OF CHANGE: 20220808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wallace Noel R.
CENTRAL INDEX KEY: 0001464265
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00644
FILM NUMBER: 221144730
MAIL ADDRESS:
STREET 1: C/O COLGATE-PALMOLIVE COMPANY
STREET 2: 300 PARK AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO
CENTRAL INDEX KEY: 0000021665
STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
IRS NUMBER: 131815595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 2123102000
MAIL ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
X0306
4
2022-08-04
0000021665
COLGATE PALMOLIVE CO
CL
0001464265
Wallace Noel R.
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK
NY
10022
1
1
Chairman, President & CEO
Common Stock
2022-08-04
4
M
0
51665.0000
72.9900
A
273455.0000
D
Common Stock
2022-08-04
4
S
0
51665.0000
81.2716
D
221790.0000
D
Common Stock
49738.0000
I
By Issuer's 401(k) Plan Trustee
Common Stock
52000.0000
I
By Spouse Trust
Common Stock
335.0000
I
By Trust
Stock Option (Right to Buy)
72.9900
2022-08-04
4
M
0
51665.0000
0.0000
D
2022-09-08
Common Stock
51665.0000
0.0000
D
Exercise of stock options awarded under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.83 to $81.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact
2022-08-08